Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control

Dafne C.A. Quixabeira, Sadia Zafar, Joao M. Santos, Victor Cervera-Carrascon, Riikka Havunen, Tatiana V. Kudling, Saru Basnet, Marjukka Anttila, Anna Kanerva, A. Hemminki

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number674400
JournalFrontiers in Immunology
Volume12
Number of pages13
ISSN1664-3224
DOIs
Publication statusPublished - 18 May 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3122 Cancers
  • 3111 Biomedicine
  • oncolytic virus
  • IL-2 variant
  • anti-tumor immunity
  • tumor microenvironment (TME)
  • virotherapy in cancer
  • HIGH-DOSE INTERLEUKIN-2
  • CELLS

Cite this